[ad_1]
NEW YORK (Reuters Health) – Taking a well-known painkiller increases the chances of survival of specific cancer types, according to a recent US study by researchers at the University of California at San Francisco.
Pain relievers, such as aspirin or ibuprofen, increase the chances of survival of malignant disease by 25 to 78%, but only in patients whose cancer has a modified gene called PIK3CA, a tumor that is raised. by a third of the tumors appearing at the level of the head and the neck.
The study involved 266 patients with head and neck cancer at the University of Pittsburgh Medical Center in Pennsylvania, 75 of whom were pregnant.
The researchers looked at the five-year survival rates of people with the disease and found that regular use of aspirin and prophylaxis boosted these proportions, but warned that it was safe for people with the disease. was acting as a preliminary result and should be replicated in a clinical trial.
[ad_2]
Source link
